DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ramatroban
Ramatroban
Inverse Agonism of SQ 29,548 and Ramatroban on Thromboxane A2 Receptor
Increased Serum Thromboxane A2 and Prostacyclin but Lower Complement C3 and C4
Nippon Shinyaku (4516)
Tricyclic Thrombin Receptor Antagonists Trizyklische Thrombin Rezeptor Antagonisten Antagonistes Tricycliques Du Recepteur De Thrombine
Prostaglandin E2–Prostoglandin E Receptor Subtype 4 (EP4) Signaling Mediates UV Irradiation-Induced Systemic Immunosuppression
10006735.Pdf
Prostanoid Receptors (Version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database
Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current
2621.Full.Pdf
Harnessing DNA-Encoded Libraries to Discover Bioactive Small Molecules
Antagonism of the Prostaglandin D Receptors DP and CRTH2 As An
Head Injury Partial Update
Inflammation/Immunology
Adjunctive Therapies to Reduce Thrombotic Events in Patients with a History of Myocardial Infarction: Role of Vorapaxar
Reproductive Health Guideline Appendix 3 – Search Strategies
Identification of Therapeutic Drugs Against COVID-19 Through Computational Investigation on Drug Repurposing and Structural Modification
The Biology of Prostaglandins and Their Role As a Target for Allergic Airway Disease Therapy
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Top View
(12) United States Patent (10) Patent No.: US 8,506,935 B2 Hale Et Al
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Customs Tariff - Schedule
Ramatroban-Based Analogues Containing Fluorine Group As Potential 18F-Labeled Positron Emission Tomography (PET) G-Protein Coupled Receptor 44 (GPR44) Tracers
Theranostics Multi-Omics Study of Silicosis Reveals the Potential
Pharmaceutical Compositions Comprising Prasugrel And
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Prostaglandin As a Target Molecule for Pharmacotherapy of Allergic Inflammatory Diseases Hiroichi Nagai1
Prostaglandin Receptor
BOC Sciences
US20080254036A1.Pdf
Community-Acquired Pneumonia: Pathogenesis of Acute Cardiac Events and Potential Adjunctive Therapies
Ramatroban As a Novel Immunotherapy for COVID-19
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Effect of a Thromboxane A2 Receptor Antagonist
Ramatroban, an Orally Bioavailable Immunomodulator and Antithrombotic Agent for Treatment of COVID-19 Disease: a Case Report
Customs Tariff - Schedule
Central CRTH2, a Second Prostaglandin D2 Receptor, Mediates Emotional Impairment in the Lipopolysaccharide and Tumor-Induced Sickness Behavior Model
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Pharmaceutical Appendix to the Tariff Schedule 2
WO 2012/123502 Al 20 September 2012 (20.09.2012) P O P C T
Schedule Clxxiii - European Union